REG - Focusrite PLC - Half Year Results
Strictly embargoed until 07:00: 24 April 2018
Focusrite Plc ("Focusrite" or "the Group")
Half Year Results for the period ended 28 February 2018
Focusrite Plc, the global music and audio products company supplying hardware and software products used by professional and amateur musicians, today announces its Half Year Results for the six months ended 28 February 2018.
Financial highlights
· Group revenue up by 21.2% (26% at constant currency1) to £38.8 million (HY17: £32.0 million)
· EBITDA2 up by 30.0% to £8.0 million (HY17: £6.1 million)
· Operating profit up by 36.3% to £6.2 million (HY17: £4.6 million)
· Profit before tax up by 26.8% to £5.8 million (HY17: £4.6 million)
· Basic earnings per share up 23.3% to 9.0p (HY17: 7.3p)
· Diluted earnings per share up by 27.1% to 8.9p (HY17: 7.0p)
· Free cash flow3 up by 49.7% to £6.4 million (HY17: £4.3 million)
· Net cash of £19.7 million (FY17: £14.2 million, HY17: £9.4 million)
· Interim dividend of 1.0 pence, up 33.3% from 0.75 pence in HY17
Operational highlights
· Revenue growth in all major regions and across both the Focusrite and Novation segments
· R&D remains core: five new products launched and five software upgrades
· New Focusrite Professional initiative progressing well
· Strong Christmas holiday season for the more consumer-priced products
· Within Novation, sales of synthesizers up 90% as our new flagship, PEAK, has gained wide recognition
· Cumulative downloads of apps now up to 8.5 million with over 500,000 active users
· Increased localisation of our eCommerce store, especially in areas less well-served by resellers
· Queen's Award for Innovation 2018; fourth time the Group has received a Queen's Award
Tim Carroll, Chief Executive Officer, commented:
"Our strategy of innovation and expansion continues to underpin our growth and we remain committed to making music easier to make for professionals and hobbyists alike. Our success is driven by our entrepreneurial and talented team, many of whom are themselves musicians, and their skill and loyalty is the bedrock of our success.
I am delighted with the Group's performance in the first half which benefited from an especially strong Christmas holiday season. Since the half year end, revenue and cash have continued to grow although, as expected, at a slower rate than in the first half. We remain confident about the outlook for the rest of the year and beyond: future product plans are taking shape, the geographic expansion continues and the strategy developments are bearing fruit."
Philip Dudderidge, Executive Chairman, added:
"It has been a great first six months. We have again increased revenue in all of our major regions and across all of our product ranges, and the whole team should be congratulated. I am particularly honoured that we have been awarded our fourth Queen's Award this April. The playing and recording of music is such a great positive force and I am so pleased that this continues to grow across the world, with Focusrite at its core."
1 Where we make reference to constant currency growth rates, these are prepared by retranslating the current year revenues using the average exchange rates that prevailed in the prior year rather than the actual exchange rates that applied in the current year.
2 Comprising of earnings adjusted for interest, taxation, depreciation and amortization. This is shown on the face of the income statement.
3 Free cash flow equals net cash inflow from operating activities less net cash used in investing activities.
Dividend timetable
The timetable for the interim dividend is as follows:
3 May 2018
Ex-dividend Date
4 May 2018
Record Date
30 May 2018
Dividend payment date
Enquiries:
Focusrite Plc:
+44 1494 836301
Tim Carroll (CEO)
Jeremy Wilson (CFO)
Panmure Gordon
+44 20 7886 2500
(Nominated Adviser and Broker)
Freddy Crossley
Belvedere Communications
+44 20 3567 0510
John West
Kim Van Beeck
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to Editors
Focusrite plc is a global music and audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and amateur musicians alike, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under four established and rapidly growing brands: Focusrite, Focusrite Pro, Novation and Ampify.
With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making industry. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesisers and grooveboxes to industry-shaping controllers and inspirational music-making apps.
The Focusrite Group has a global customer base with a distribution network covering approximately 160 territories. Focusrite is headquartered in High Wycombe, UK, with marketing offices in Los Angeles and Hong Kong. Focusrite plc is traded on the AIM market, London Stock Exchange.
Business and operating review
Overview
Focusrite is pleased to report Half Year Results that show continued strong organic growth across the business. Year-on-year growth in the first half of the current financial year continued, with revenue growing by 21.2%.
Total revenue for the period grew to £38.8 million (HY17: £32.0 million), resulting in an operating profit of £6.2 million (HY17: £4.6 million), with EBITDA up to £8.0 million (HY17: £6.1 million).
Revenue growth on a constant currency basis accelerated further to 26% (HY17: 12%). The Group had an especially strong Christmas holiday season for the more consumer-priced products. We also saw the benefit of our focused efforts in previously identified geographies with growth potential, and growth in our professional product lines from our newly formed Professional division.
Research and development remains core to our strategy and a key driver of our growth. During this half year, we introduced five new products and delivered five upgrades to existing products. Additionally, we delivered new tools focused on simplifying the new user experience, thereby significantly reducing the actual time between first contact with our products and making music. These efforts have been well received by our customers and played a key role in the strong performance reported today, especially for our products and solutions aimed at the new user.
Sales grew in all major geographies and particularly in the USA. We have invested resources into high-potential growth markets such as Asia and Latin America which have begun generating significant year-on-year gains. Additionally, we continue to grow in our other more established markets such as the UK and mainland Europe.
Our strategy of innovation and expansion continues to underpin our growth and we remain committed to making music easier to make for professionals and hobbyists alike. Our success is driven by our entrepreneurial and talented team, many of whom are themselves musicians, and their skill and loyalty is the bedrock of our success.
We will add more people globally to our sales, marketing, engineering and product groups to support our future growth plans.
Operating review
We continue to exceed our core growth KPI benchmarks and consequently the Group continues to perform well both operationally and financially. The management team is committed to pursuing its stated goals of innovation; disruption; making music easier to make; and expanding our addressable market. We have firmly established ourselves as a market leader and our aim is to capitalise further on this by continuing to excite and empower our customers. By improving the product and customer experience, we will seek to extend the customer lifecycle, encouraging them to use our products longer throughout their music-making lifetime.
Segmental analysis - markets
Six months to
28 February 2018 (unaudited)Six months to
28 February 2017 (unaudited)Year to
31 August 2017 (audited)£'000
£'000
£'000
Continuing operations
USA
16,123
13,246
27,990
Europe, Middle East and Africa
15,997
12,958
25,153
Rest of World
6,699
5,816
12,912
Consolidated revenue
38,819
32,020
66,055
Regionally, the USA grew by 34% on a constant currency basis. This was driven by a number of factors, including continued success and market share gain in our 2nd generation Scarlett series of audio interfaces, as well as continued growth of our Launch products for electronic musicians, and progress by our new Focusrite Professional division into new vertical markets such as post-production.
In Europe, Middle East and Africa, sales were up by 19% on a constant currency basis. All of the major territories (UK, Germany and mainland Europe) have experienced solid growth. Overall, we have seen increased stabilisation in the market along with an increased awareness and acceptance of our Focusrite and Novation solutions.
The Rest of World grew at 26% on a constant currency basis, and in particular Asia performed well showing a healthy increase following our investment in a local office and the addition of more people. We continue to invest more resources into regional localisation and support to maintain our growth momentum.
eCommerce
The Group's eCommerce store, which launched in March 2016, now accounts for over 1% of the Group's total revenue and this continues to grow. In addition to providing a direct revenue stream, the store creates improved conversion through all sales channels. We have expanded this and it now ships a wider range of products globally, with targeted regional strategies in place to support operations. Part of our recent efforts include localisation in Spanish, Korean and Japanese languages.
Segmental analysis - products
Six months to
28 February 2018Six months to
28 February 2017Year to
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Revenue from external customers
Focusrite
25,693
20,856
44,552
Novation
11,419
9,604
18,862
Distribution
1,707
1,560
2,641
Total
38,819
32,020
66,055
Alongside engineering, innovation is paramount to our success and we continue to spend around 6% of annual revenue on research and development to provide a constant pipeline of new and relevant products for our various channels.
We launched five new products during the period: the Clarett USB family (three products), Red 16 and Red X2P, as well as significant software updates including those for Circuit, Launchpad, Groovebox and BlocsWave. These new products and updates are across different price segments and target customer markets, giving us further penetration and reach. Feedback from the consumer, retailer and distribution channels has been positive and acceptance so far has been pleasing.
Focusrite
Among existing products, our 2nd generation Scarlett USB audio interface range has continued to gain market share since its launch in June 2016. The Clarett range has also seen solid growth of 28% year on year, mostly driven by the launch of our USB range this half year. Rednet and Red ranges have also grown as our newly formed Focusrite Professional division begins netting strategic sales wins in previously untargeted vertical markets such as the post-production and broadcast sectors.
Novation
Launchpad, Novation's grid instrument that comes pre-loaded with Ableton Live Lite software, continues to grow worldwide with revenue increasing by 26% over the period. This is due, in part, to a wider market acceptance of grid controllers, especially amongst younger musicians, and the addition of more consumer electronic partners added to the distribution channel. This move has created greater reach into both new and existing mainstream audiences. Online sales remain an area of importance for the Group, as we seek to stay relevant to the way consumers shop and spend.
Additionally, within the Novation business the Synthesizer category is up 90% year on year as our new flagship offering, PEAK, establishes itself as a best-in-class solution for professionals in electronic music.
Circuit, the inspirational grid-based groove box, continues to build a foundation in the market. We are pleased with its progress and are watching the groove box product space carefully to ascertain how we should progress in this specific area.
The London Innovation division continues to disrupt the market with a growing portfolio of innovative music-making software. The new Ampify brand continues to drive awareness of music creation to a vast new market of music creators, which in turn supports the growth of the Focusrite and Novation brands. The suite of music apps has now reached an impressive 8.5 million downloads, and this number is increasing at around 200,000 per month. Software is a crucial component of the business strategy to solve the problems of music creation, increasing customer loyalty and overall lifetime value.
Distribution
Focusrite's distribution of adjacent products, such as KRK monitors and sE microphones, remains a small overall proportion of Group revenue, but it is profitable and it remains important to us as it offers add-on products within the music-making industry and provides us with valuable market feedback, insight and knowledge.
Financial review
Revenue and profit
Group revenue for the half year was £38.8 million, up 21.2% on the previous year and up 26% on a constant currency basis. All major product groups and geographical areas increased, with the biggest increases in the Launch range of products (within the Novation segment), which had a volume increase of 24%, and the Scarlett range of products (within the Focusrite segment), which had a volume increase of 38%.
The gross margin also increased to 41.7% (HY17: 40.1%), helped by the stronger Euro and closer monitoring of the discounts given to distributors and dealers. As explained at the last year end, operating costs were increased in sales and marketing to support the strategic initiatives around the professional products within the Focusrite segment and the eCommerce sales channel. Operating costs were increased by 20.4%. Taking these factors into account, EBITDA for the period grew by 30.0% to £8.0 million (HY17: £6.1 million).
Capitalisation of research and development
The Group typically spends approximately 6% of its revenue on research and development, developing future ranges of products. The normal product life is between three and six years. Where costs can be reliably assigned to a particular product, the costs are capitalised and written-off over three years. Typically around 70% of R&D costs are capitalised. The net income statement effect of the capitalisation less the amortisation in the period was a gain of £0.1 million (HY17: a gain of £0.3 million).
Foreign currency
Six months to
28 February 2018Six months to
28 February 2017Year to
31 August 2017Exchange rates
Average $:£
1.35
1.26
1.27
Average €:£
1.13
1.16
1.16
Period end $:£
1.38
1.24
1.29
Period end €:£
1.13
1.17
1.09
The movements in exchange rates were far smaller than in the previous year. The US Dollar weakened by 7% and the Euro strengthened marginally. The US Dollar accounts for approximately 60% of Group revenue (North America, Asia and Latin America) and all of the purchases of product from Chinese contract manufacturers. Therefore there is a substantial natural hedge in place. Consequently, the 7% weakening of the US Dollar reduced revenue but had little impact on profit.
The Euro accounts for approximately 25% of Group revenue with very little related Euro cost. The Group has hedged approximately 2/3 of its Euro flows to convert them into Sterling at an average rate of €1.12. Therefore the blended Euro exchange rate in the period was €1.12 (HY17: €1.25).
The Group has hedged approximately 2/3 of the Euro cash flows for the rest of this financial year (at an average rate of €1.12) and approximately 25% of Euro cash flows for 2018/19 at an average rate of €1.07.
The Group uses hedge accounting, meaning that the hedging contracts have been matched to the associated income flows. Therefore, provided that the hedge remains effective, movements in the fair value of unexpired hedge contracts are shown in a hedging reserve in the balance sheet.
Net financing charges
The net financing charges were £0.4 million (HY17: £nil) due largely to the revaluation of bank balances held in US Dollars.
Profit before tax
Reported profit before tax grew to £5.8 million, up 26.8% on the prior period (HY17: £4.6 million) driven by all of the factors discussed above, most particularly the higher revenue and the increased gross margin.
Tax
The standard rate of Corporation Tax in the UK is 19%. The Group gains additional tax relief on the substantial research and development effort, which reduces the effective tax rate to 12% (HY17: 12%).
Profit after tax and earnings per share
Profit after tax was £5.1 million, up 26.6% on the prior year (HY17: £4.0 million).
The reported basic earnings per share increased by 23.3% to 9.0 pence (HY17: 7.3 pence). This was lower than the increase in the profit after tax because the number of shares in issue was increased due largely to the vesting of 1.4 million options which were satisfied out of the Employee Benefit Trust.
A much smaller number of new share options was issued during the period so the diluted earnings per share increased by 27.1% to 8.9 pence (HY17: 7.0 pence), a rate similar to the increase in profit before tax.
Balance sheet
Non-current assets totalled £6.6 million (28 February 2017: £6.7 million). These are mainly capitalised research and development costs and during the period capitalised R&D costs were similar to the amortisation.
Stock as at 28 February 2018 was £10.9 million (28 February 2017: £10.1 million). This 7% increase compares well with the 21% increase in revenue, signalling the continued positive efforts to manage stock carefully whilst ensuring that the business has the ability to satisfy customer demand.
Debtors totalled £10.9 million (28 February 2017: £10.2 million). The Group has an effective credit control process including credit limits and a potential refusal to supply if the customer has overdue debts. At 28 February 2018 the debtors balance represented 49 days' sales (28 February 2017: 51 days).
Trade and other payables increased to £9.1 million (28 February 2017: £6.4 million). This was due to the increased stock purchases close to the period end.
Cash flow
The conversion of profit to cash has been strong with free cash flow up 49.7% to £6.4 million (HY17: £4.3 million). In part, this was assisted by control over the working capital. Normally, it would be reasonable to assume an increase in working capital of about 20% of the increase in revenue, driven by higher debtors and a higher value of stock to service that demand. In this period, the movement in working capital has been an inflow (decrease) of £1.0 million (HY17: £nil), due to a reduction in debtors since the prior year end.
Overall, cash flow from operating activities was 105% (HY17: 101%) of EBITDA and free cash flow was 16% of revenue (HY17: 13%). Both of these measures have been strong; however, it should be noted that the average of free cash flow as a percentage of revenue since the IPO has been approximately 7%.
As a result of this cash generation, cash balances grew from £14.2 million in August 2017 to £19.7 million as at 28 February 2018. It is intended that this will fund the Group's entry into related market segments, which is a key element of the Group's growth strategy.
Dividend
At the last year end, the Group announced that it would move towards an ongoing dividend cover of 4-5x. Therefore, as a step towards that, the interim dividend is raised by 33.3% from 0.75 pence to 1.0 pence per share.
Outlook and current trading
The first half benefited from an especially strong Christmas holiday season. Since the half year end, revenue and cash have continued to grow although, as expected, at a slower rate than in the first half. We remain confident about the outlook for the rest of the year and beyond: future product plans are taking shape, the geographic expansion continues and the strategy developments are bearing fruit.
Tim Carroll Jeremy Wilson
Chief Executive Officer Chief Financial Officer
Condensed Consolidated Income Statement
For the six months ended 28 February 2018
Note
Six months to
28 February 2018
Six months to
28 February 2017
Year to
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Revenue
2
38,819
32,020
66,055
Cost of sales
(22,619)
(19,165)
(39,704)
Gross profit
16,200
12,855
26,351
Administrative expenses
(9,970)
(8,284)
(16,881)
EBITDA (non-GAAP measure)
7,969
6,131
13,109
Depreciation and amortisation
(1,739)
(1,560)
(3,639)
Operating profit
6,230
4,571
9,470
Finance income
1
52
86
Finance costs
(398)
(24)
(44)
Profit before tax
5,833
4,599
9,512
Income tax expense
4
(709)
(552)
(959)
Profit for the period from continuing operations
5,124
4,047
8,553
Earnings per share
From continuing operations
Basic (pence per share)
6
9.0
7.3
15.4
Diluted (pence per share)
6
8.9
7.0
14.8
Condensed Consolidated Statement of Other Comprehensive Income
For the six months ended 28 February 2018
Six months to
28 February 2018
Six months to
28 February 2017
Year to
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Profit for the period
5,124
4,047
8,553
Items that may be reclassified subsequently to the income statement
Exchange differences on translation of foreign operations
(30)
29
(8)
Gain/(loss) on forward foreign exchange contracts designated and effective as a hedging instrument
743
700
659
Tax on hedging instrument
(144)
(142)
(134)
Total comprehensive income for the period
5,693
4,634
9,070
Profit attributable to:
Equity holders of the Company
5,693
4,634
9,070
5,693
4,634
9,070
Condensed Consolidated Statement of Financial Position
Note
28 February 2018
28 February 2017
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Assets
Non-current assets
Goodwill
419
419
419
Other intangible assets
4,818
4,823
4,544
Property, plant and equipment
1,369
1,502
1,369
Total non-current assets
3
6,606
6,744
6,332
Current assets
Inventories
10,894
10,145
8,334
Trade and other receivables
10,811
10,234
12,952
Derivative financial instruments
7
258
-
-
Cash and cash equivalents
7
19,734
9,391
14,174
Total current assets
41,697
29,770
35,460
Total assets
48,303
36,514
41,792
Equity and liabilities
Capital and reserves
Share capital
58
58
58
Share premium
114
-
-
Merger reserve
14,595
14,595
14,595
Merger difference reserve
(13,147)
(13,147)
(13,147)
Translation reserve
1
68
31
Hedging reserve
210
(356)
(389)
Treasury reserve
(2)
(3)
(3)
Retained earnings
36,451
27,428
31,739
Equity attributable to owners of the Company
38,280
28,643
32,884
Total equity
38,280
28,643
32,884
Current liabilities
Trade and other payables
9,126
6,390
7,720
Current tax liabilities
257
523
459
Derivative financial instruments
7
-
443
484
Total current liabilities
9,383
7,356
8,663
Non-current liabilities
Deferred tax
640
515
245
Total liabilities
10,023
7,871
8,908
Total equity and liabilities
48,303
36,514
41,792
Condensed Consolidated Statements of Changes in Equity
For the six months ended 28 February 2018
Share capital
Share premium
Merger reserve
Merger difference reserve
Translation reserve
Hedging reserve
Treasury share reserve1
Retained earnings2
Total
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
Balance at 1 September 2017
58
-
14,595
(13,147)
31
(389)
(3)
31,739
32,884
Profit for the period
-
-
-
-
-
-
-
5,124
5,124
Other comprehensive income for the period
-
-
-
-
(30)
599
-
-
569
Total comprehensive income for the period
-
-
-
-
(30)
599
-
5,124
5,693
Transactions with owners of the Company:
Share-based payment deferred tax deduction in excess of remuneration expense
-
-
-
-
-
-
-
(254)
(254)
Share-based payment current tax deduction in excess of remuneration expense
-
-
-
-
-
-
-
661
661
Shares from EBT exercised
-
-
-
-
-
-
1
188
189
New shares issued
-
114
-
-
-
-
-
-
114
Share-based payments
-
-
-
-
-
-
103
103
Dividends paid
-
-
-
-
-
-
-
(1,110)
(1,110)
Balance at 28 February 2018
58
114
14,595
(13,147)
1
210
(2)
36,451
38,280
1The reserve for the Company's treasury shares comprises the cost of the Company's shares held by the Group. At 28 February 2018, the Employee Benefit Trust held 1,188,025 of the Company's shares (six months ended 28 February 2017: 2,586,845).
2Of the retained earnings totalling £36,451,000, £615,000 (28 February 2017: £421,000) relates to the gain on exercise of share options from the EBT and is therefore non-distributable.
Condensed Consolidated Statements of Changes in Equity (Continued)
For the six months ended 28 February 2017
Share capital
Merger reserve
Merger difference reserve
Translation reserve
Hedging reserve
Treasury share reserve
Retained earnings
Total
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
Balance at 1 September 2016
58
14,595
(13,147)
39
(914)
(5)
23,251
23,877
Profit for the period
-
-
-
-
-
-
4,047
4,047
Other comprehensive income for the period
-
-
-
29
558
-
-
587
Total comprehensive income for the period
-
-
-
29
558
-
4,047
4,634
Transactions with owners of the Company:
Share-based payment deferred tax deduction in excess of remuneration expense
-
-
-
-
-
-
(30)
(30)
Share-based payment current tax deduction in excess of remuneration expense
-
-
-
-
-
-
556
556
Shares from EBT exercised
-
-
-
-
-
2
250
252
Share-based payments
-
-
-
-
-
-
75
75
Dividends paid
-
-
-
-
-
-
(721)
(721)
Balance at 28 February 2017
58
14,595
(13,147)
68
(356)
(3)
27,428
28,643
Condensed Consolidated Statements of Changes in Equity (Continued)
For the year ended 31 August 2017
Share capital
Merger reserve
Merger difference reserve
Translation reserve
Hedging reserve
Treasury share reserve
Retained earnings
Total
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
Balance at 1 September 2016
58
14,595
(13,147)
39
(914)
(5)
23,251
23,877
Profit for the period
-
-
-
-
-
-
8,553
8,553
Other comprehensive income for the period
-
-
-
(8)
525
-
-
517
Total comprehensive income for the period
-
-
-
(8)
525
-
8,553
9,070
Transactions with owners of the Company:
Share-based payment deferred tax deduction in excess of remuneration expense
-
-
-
-
-
-
114
114
Share-based payment current tax deduction in excess of remuneration expense
-
-
-
-
-
-
558
558
Shares from EBT exercised
-
-
-
-
-
2
256
258
Share-based payments
-
-
-
-
-
-
145
145
Dividends paid
-
-
-
-
-
-
(1,138)
(1,138)
Balance at 31 August 2017
58
14,595
(13,147)
31
(389)
(3)
31,739
32,884
Consolidated Statement of Cash Flow
For the six months ended 28 February 2018
Six months to
28 February 2018Six months to
28 February 2017Year to
31 August 2017
£'000
£'000
£'00
Cash flows from operating activities
Profit for the period
5,124
4,047
8,553
Adjustments for:
Income tax expense
709
552
959
Net finance charge/(income)
397
(28)
(42)
Loss/(profit) on disposal of property, plant and equipment
-
8
(8)
Amortisation of intangibles
1,399
1,198
2,950
Depreciation of property, plant and equipment
340
362
689
Share-based payment charge
103
75
145
Operating cash flow before movements in working capital
8,072
6,214
13,246
Decrease/(increase) in trade and other receivables
2,141
990
(1,728)
(Increase)/decrease in inventories
(2,560)
1,216
3,027
Increase/(decrease) in trade and other payables
1,406
(2,222)
(892)
Operating cash flow before interest and tax paid
9,059
6,198
13,653
Net interest paid
(29)
(22)
(42)
Income tax paid
(253)
(56)
(633)
Cash generated by operations
8,777
6,120
12,978
Net foreign exchange movement
(397)
78
84
Net cash inflow from operating activities
8,380
6,198
13,062
Cash flows from investing activities
Purchases of property, plant and equipment
(340)
(299)
(493)
Development of intangible assets
(1,673)
(1,645)
(3,121)
Net cash used in investing activities
(2,013)
(1,944)
(3,614)
Cash flows from financing activities
Issue of equity shares
303
252
258
Equity dividends paid
(1,110)
(721)
(1,138)
Net cash used in financing activities
(807)
(469)
(880)
Net increase in cash and cash equivalents
5,560
3,785
8,568
Cash and cash equivalents at beginning of the period
14,174
5,606
5,606
Cash and cash equivalents at end of the period
19,734
9,391
14,174
Notes to the Condensed Consolidated Interim Financial Statements
1. Basis of preparation and significant accounting policies
Focusrite Plc (the 'Company') is a company incorporated in the UK. The condensed consolidated interim financial statements ('interim financial statements') as at and for the six months ended 28 February 2018 comprised the Company and its subsidiaries (together referred to as the 'Group').
The Group is a business engaged in the development, manufacture and marketing of professional audio and electronic music products.
Statement of compliance
The interim financial statements are for the six months ended 28 February 2018 and are presented in pounds Sterling ('GBP'). This is the functional currency of the Group. The statement is presented to the nearest £1,000 ("£'000"). The interim financial report has been prepared in accordance with the International Financial Reporting Standards ('IFRS'), International Accounting Standards ('IAS') and interpretations currently endorsed by the International Accounting Standards Board ('IASB') and its committees as adopted by the EU and as required to be adopted by AIM listed companies. AIM listed companies are not required to comply with IAS 34 'Interim Financial Reporting' and accordingly the Company has taken advantage of this exemption. They do not include all the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual consolidated financial statements as at and for the year ended 31 August 2017.
These interim financial statements were authorised for issue by the Company's Board of Directors on 24 April 2018.
Significant accounting policies
The interim financial statements have been prepared in accordance with the accounting policies adopted in the Group's financial statements for the year ended 31 August 2017.
1.1 Basis of consolidation
The consolidated financial statements comprise the financial statements of the Company and subsidiaries controlled by the Company drawn up to 28 February 2018.
1.2 Subsidiaries
Subsidiaries are entities controlled by the Group. Control exists when the Group has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, the Group takes into consideration potential voting rights that are currently exercisable. The acquisition date is the date on which control is transferred to the acquirer. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date control ceases.
1.3 Going concern
The Board of Directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.
1.4 Earnings per share
The Group presents basic and diluted earnings per share ('EPS') data for its ordinary shares. Basic EPS is calculated by dividing the profit attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. For diluted EPS, the weighted average number of ordinary shares is adjusted for the dilutive effect of potential ordinary shares arising from the exercise of granted share options.
1.5 Accounting estimates and judgements
In application of the Group's accounting policies, the Directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
In preparing these condensed consolidated interim financial statements, the significant judgements made by the Directors in applying the Group's accounting policies and key sources of estimation uncertainty were the same as those applied to the Group's financial statements for the year ended 31 August 2017.
1.6 Foreign currencies
The individual financial statements of each subsidiary are presented in the currency of the primary economic environment in which it operates (its functional currency). Sterling is the predominant functional currency of the Group and presentation currency for the consolidated financial information.
In preparing the financial statements of the individual companies, transactions in currencies other than the entity's functional currency (foreign currencies) are recognised at the rates of exchange prevailing on the dates of the transactions. At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing at that date. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.
Exchange differences are recognised in profit or loss in the period in which they arise except for:
· Exchange differences on transactions entered into to hedge certain foreign currency risks
· Exchange differences on monetary items receivable from or payable to a foreign operation for which settlement is neither planned nor likely to occur (therefore forming part of the net investment in the foreign operation), which are recognised initially in other comprehensive income and reclassified from equity to profit or loss on disposal or partial disposal of the net investment.
For the purpose of presenting consolidated financial information, the assets and liabilities of the Group's foreign operations are translated at exchange rates prevailing on the balance sheet date. Income and expense items are translated at the average exchange rates for the period, unless exchange rates fluctuate significantly during that period, in which case the exchange rates at the date of the transactions are used. Exchange differences arising, if any, are recognised in the income statement.
1.7 Hedge accounting
For the year ended 31 August 2016 and subsequent years, the Group has adopted hedge accounting for qualifying transactions. Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to their fair value at each balance sheet date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship. The Group designates certain derivatives as either hedges of the fair value of recognised assets or liabilities of firm commitments (fair value hedges), hedges of highly probable forecast transactions or hedges of foreign currency risk of firm commitments (cash flow hedges), or hedges of net investments in foreign operations.
Cash flow hedges
Where a derivative financial instrument is designated as a hedge of the variability in cash flows of a recognised asset or liability, or a highly probable forecast transaction, the effective part of any gain or loss on the derivative financial instrument is recognised directly in the hedging reserve. Any ineffective portion of the hedge is recognised immediately in the income statement.
For cash flow hedges, the associated cumulative gain or loss is removed from equity and recognised in the income statement in the same period or periods during which the hedged forecast transaction affects profit or loss.
When a hedging instrument expires or is sold, terminated or exercised, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognised in accordance with the above policy when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealised gain or loss recognised in equity is recognised in the income statement immediately.
A derivative with a positive fair value is recognised as a financial asset whereas a derivative with a negative fair value is recognised as a financial liability.
2. Revenue
An analysis of the Group's revenue is as follows:
Six months to
28 February 2018 (unaudited)Six months to
28 February 2017 (unaudited)Year to
31 August 2017 (audited)£'000
£'000
£'000
Continuing operations
USA
16,123
13,246
27,990
Europe, Middle East and Africa
15,997
12,958
25,153
Rest of World
6,699
5,816
12,912
Consolidated revenue
38,819
32,020
66,055
3. Operating segments
Products and services from which reportable segments derive their revenues
Information reported to the Group's Chief Executive Officer (who has been determined to be the Group's Chief Operating Decision Maker) for the purposes of resource allocation and assessment of segment performance is focused on the main product groups which the Group sells. The Group's reportable segments under IFRS 8 are therefore as follows:
Focusrite - Sales of Focusrite and Focusrite Pro branded products
Novation - Sales of Novation and Ampify branded products
Distribution - Distribution of third party brands, including KRK speakers, Stanton, Cerwin Vega, Cakewalk and sE Electronics
The revenue and profit generated by each of the Group's operating segments are summarised as follows:
Six months to
28 February 2018Six months to
28 February 2017Year to
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Revenue from external customers
Focusrite
25,693
20,856
44,552
Novation
11,419
9,604
18,862
Distribution
1,707
1,560
2,641
Total
38,819
32,020
66,055
Segment profit
Focusrite
12,503
9,873
20,221
Novation
6,000
4,773
9,198
Distribution
481
434
711
18,984
15,080
30,130
Central distribution costs and administrative expenses
(12,754)
(10,509)
(20,660)
Operating profit
6,230
4,571
9,470
Finance income
1
52
86
Finance costs
(398)
(24)
(44)
Profit before tax
5,833
4,599
9,512
Tax
(709)
(552)
(959)
Profit after tax
5,124
4,047
8,553
Segment profit represents the profit earned by each segment without allocation of the share of central administration costs, including Directors' salaries, finance income and finance costs, and income tax expense. This is the measure reported to the Group's Chief Executive Officer for the purpose of resource allocation and assessment of segment performance.
Central administration costs comprise principally the employment-related costs and other overheads incurred by the Group. Also included within central administration costs is the charge relating to the share option scheme of £103,000 for the six-month period to 28 February 2018 (six months to 28 February 2017: £75,000; year to 31 August 2017: £145,000).
Segment net assets and other segment information
Management does not make use of segmental data relating to net assets and other balance sheet information for the purposes of monitoring segment performance and allocating resources between segments. Accordingly, other than the analysis of the Group's non-current assets by region shown below, this information is not available for disclosure in the consolidated financial information.
The Group's non-current assets, analysed by region, were as follows:
28 February 2018
28 February 2017
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Non-current assets
USA
99
59
52
Europe, Middle East and Africa
5,865
5,998
5,676
Rest of World
642
687
604
Total non-current assets
6,606
6,744
6,332
4. Taxation
The tax charge for the six months to 28 February 2018 is based on the estimated tax rate for the full year in each jurisdiction.
5. Dividends
The following equity dividends have been declared:
Six months to
28 February 2018 (unaudited)Six months to
28 February 2017 (unaudited)Year to
31 August 2017
(audited)Dividend per qualifying ordinary share
1.00p
0.75p
2.70p
During the period, the Company paid a final dividend in respect of the year ended 31 August 2017 of 1.95 pence per share, amounting to £1,110,000.
6. Earnings per share
Reported earnings per share
The calculation of the basic and diluted earnings per share is based on the following data:
Six months to
28 February2018
(unaudited)
Six months to
28 February 2017(unaudited)
Year to
31 August2017
(audited)
Earnings
£'000
£'000
£'000
Earnings for the purposes of basic and diluted earnings per share being net profit for the period
5,124
4,047
8,553
Six months to
28 February2018
Six months to
28 February2017
Year to
31 August2017
number
number
number
Number of shares
'000
'000
'000
Weighted average number of ordinary shares for the purposes of basic earnings per share calculation
56,690
55,298
55,432
Effect of dilutive potential ordinary shares:
EMI share option scheme and unapproved share option plan
1,151
2,356
2,357
Weighted average number of ordinary shares for the purposes of diluted earnings per share calculation
57,841
57,654
57,789
Earnings per share
Pence
Pence
Pence
Basic earnings per share
9.0
7.3
15.4
Diluted earnings per share
8.9
7.0
14.8
At 28 February 2018, the total number of ordinary shares issued and fully paid was 58,111,639. This included 1,188,025 shares held by the Employee Benefit Trust ('EBT') to satisfy options vesting in future years. The operation of this Employee Benefit Trust is funded by the Group so the EBT is required to be consolidated, with the result that the weighted average number of ordinary shares for the purpose of the basic earnings per share calculation is the net of the weighted average number of shares in issue (58,094,838) less the weighted average number of shares held by the Employee Benefit Trust (1,405,082). It should be noted that the only right relinquished by the Trustees of the Employee Benefit Trust is the right to receive dividends. In all other respects, the shares held by the Employee Benefit Trust have full voting rights.
The effect of dilutive potential ordinary share issues is calculated in accordance with IAS 33 and arises from the employee share options currently outstanding, adjusted by the profit element as a proportion of the average share price during the period.
7. Financial instruments
The fair value of the Group's derivative financial instruments is calculated using the quoted prices. Where such prices are not available, a discounted cash flow analysis is performed using applicable yield curve for the duration of the instruments for non-optional derivatives, and option pricing model for optional derivatives. Foreign currency forward contracts are measured using quoted forward exchange rates and yield curves derived from quoted interest rates matching maturities of the contract.
IFRS 13 Fair Value Measurements requires the Group's derivative financial instruments to be disclosed at fair value and categorised in three levels according to the inputs used in the calculation of their fair value.
Financial instruments carried at fair value should be measured with reference to the following levels:
· Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;
· Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or
liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and
· Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).
The financial instruments held by the Group that are measured at fair value all related to financial assets/(liabilities) measured using a Level 2 valuation method.
The fair value of financial assets and liabilities held by the Group are:
28 February 2018
28 February 2017
31 August 2017
(unaudited)
(unaudited)
(audited)
£'000
£'000
£'000
Financial assets
Amortised cost
Cash and cash equivalents
19,734
9,391
14,174
Trade and other receivables
10,243
9,211
11,203
Designated cash flow hedge relationships
Derivative financial assets designated and effective as cash flow hedging instruments
258
-
-
30,235
18,602
25,377
Financial liabilities
Designated cash flow hedge relationships
Derivative financial liabilities designated and effective as cash flow hedging instruments
-
443
484
Amortised cost
Trade and other payables
8,861
3,468
4,042
8,861
3,911
4,526
Independent Review Report to Focusrite Plc
Conclusion
We have been engaged by the company to review the condensed set of financial statements in the half-yearly report for the six months ended 28 February 2018 which comprises the Condensed Consolidated Income Statement, Condensed Consolidated Statement of Other Comprehensive Income, Condensed Consolidated Statement of Financial Position, Condensed Consolidated Statement of Changes in Equity, Condensed Consolidated Statement of Cash Flow and the related explanatory notes.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly report for the six months ended 28 February 2018 is not prepared, in all material respects, in accordance with the recognition and measurement requirements of International Financial Reporting Standards (IFRSs) as adopted by the EU and the AIM Rules.
Scope of review
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the half-yearly report and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Directors' responsibilities
The half-yearly report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly report in accordance with the AIM Rules.
As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the EU. The directors are responsible for preparing the condensed set of financial statements included in the half-yearly financial report in accordance with the recognition and measurement requirements of IFRSs as adopted by the EU.
Our responsibility
Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the half-yearly report based on our review.
The purpose of our review work and to whom we owe our responsibilities
This report is made solely to the company in accordance with the terms of our engagement. Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached.
Peter Meehan
for and on behalf of KPMG LLP
Chartered Accountants
One Snowhill
Snow Hill Queensway
Birmingham
B4 6GH
24 April 2018
This information is provided by RNSThe company news service from the London Stock ExchangeENDIR IJMRTMBITBFP
Recent news on Focusrite
See all newsREG - Focusrite PLC - TR-1
AnnouncementREG - Focusrite PLC - Investor Presentation via Investor Meet Company
AnnouncementREG - Focusrite PLC - Notice of Interim Results
AnnouncementREG - Focusrite PLC - Notification of PDMR Transactions
AnnouncementREG - Focusrite PLC - TR-1
Announcement